We sincerely thank the authors for their interest in our review entitled “From traditional to artificial intelligence-driven approaches: Revolutionizing personalized and precision nutrition in inflammatory bowel disease” and for their thoughtful comments. In addition, we appreciate the opportunity to clarify several aspects of our manuscript. First, regarding the section on artificial intelligence (AI), we agree that the current evidence supporting AI-driven nutritional decision-making in inflammatory bowel disease (IBD) remains limited and that prospective clinical validation studies are still needed. Anyway, our aim was not to show AI-based tools as established standards of care, but rather to discuss their emerging potential within the broader
Reply to: From traditional to artificial intelligence-driven approaches: Revolutionizing personalized and precision nutrition in inflammatory bowel disease / Baldi, S., Sarikaya, D., Lotti, S., Cuffaro, F., Fink, D., Colombini, B., Sofi, F., Amedei, A.. - In: CLINICAL NUTRITION ESPEN. - ISSN 2405-4577. - STAMPA. - 75:(2026), pp. 103450.103450-103450.103450. [10.1016/j.clnesp.2026.103450]
Reply to: From traditional to artificial intelligence-driven approaches: Revolutionizing personalized and precision nutrition in inflammatory bowel disease
Baldi, Simone
Writing – Original Draft Preparation
;Lotti, SofiaWriting – Original Draft Preparation
;Cuffaro, FrancescaWriting – Original Draft Preparation
;Fink, DorianWriting – Original Draft Preparation
;Colombini, BarbaraWriting – Review & Editing
;Sofi, FrancescoWriting – Review & Editing
;Amedei, AmedeoWriting – Review & Editing
2026
Abstract
We sincerely thank the authors for their interest in our review entitled “From traditional to artificial intelligence-driven approaches: Revolutionizing personalized and precision nutrition in inflammatory bowel disease” and for their thoughtful comments. In addition, we appreciate the opportunity to clarify several aspects of our manuscript. First, regarding the section on artificial intelligence (AI), we agree that the current evidence supporting AI-driven nutritional decision-making in inflammatory bowel disease (IBD) remains limited and that prospective clinical validation studies are still needed. Anyway, our aim was not to show AI-based tools as established standards of care, but rather to discuss their emerging potential within the broader| File | Dimensione | Formato | |
|---|---|---|---|
|
PIIS2405457726005474.pdf
Accesso chiuso
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Tutti i diritti riservati
Dimensione
375.13 kB
Formato
Adobe PDF
|
375.13 kB | Adobe PDF | Richiedi una copia all'autore |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.



